Remove Chronic Pain Remove Clinical Trials Remove DEA Remove Recreational
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Drug Enforcement Agency (“DEA”). Published Via JD Supra. 360bbb-0a(a)(2).

Law 105
article thumbnail

What’s the deal with ketamine? Q&A on Special K

The Cannigma

Previously thought of as either a horse tranquilizer or a dissociative recreational party drug, ketamine has re-emerged as a promising therapeutic agent to treat pain, PTSD, depression, anxiety and more. Ketamine was approved by the FDA in 1970 and was immediately put to use as an important tool for war medics in the Vietnam War.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.